Jupiter Neurosciences grants 259K stock options
Jupiter Neurosciences, Inc. reported that Chief Scientific Officer Hayward Marshall received a grant of 259,231 stock options on June 2, 2026 as a discretionary bonus for services during fiscal 2025.
Rhea-AI Filing Summary
Jupiter Neurosciences, Inc. reported that Chief Scientific Officer Hayward Marshall received a grant of 259,231 stock options on June 2, 2026 as a discretionary bonus for services during fiscal 2025. The options have an exercise price of $0.2783 per share and expire on June 2, 2036.
The options relate to 259,231 shares of common stock and were granted under the company’s 2025 Equity Incentive Plan. They vest over three years starting September 2, 2026, in equal quarterly installments, contingent on Mr. Marshall’s continued employment, and his total options following this grant are 259,231.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 259,231 shares
Grant/Award
1 txn
Insider
Hayward Marshall A.
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 259,231 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 259,231 contracts (Direct)
Footnotes (1)
- F1. 259,231 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date.
Key Figures
Option grant size: 259,231 options
Exercise price: $0.2783 per share
Underlying shares: 259,231 shares
+3 more
6 metrics
Option grant size
259,231 options
Granted June 2, 2026 as discretionary bonus for fiscal 2025
Exercise price
$0.2783 per share
Price to exercise each option for common stock
Underlying shares
259,231 shares
Common stock underlying the option grant
Expiration date
June 2, 2036
Options expire if not exercised by this date
Vesting start
September 2, 2026
Vests over three years in equal quarterly installments
Post-grant derivative holdings
259,231 options
Total stock options held after this transaction
Key Terms
2025 Equity Incentive Plan, discretionary bonus, Stock Option, vesting
4 terms
2025 Equity Incentive Plan financial
"259,231 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus"
discretionary bonus financial
"259,231 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered"
Stock Option financial
"security_title: Stock Option"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"The options vest over three years commencing from September 2, 2026 in equal quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Jupiter Neurosciences (JUNS) disclose in this Form 4 for Hayward Marshall?
Jupiter Neurosciences disclosed that Chief Scientific Officer Hayward Marshall received a grant of 259,231 stock options as a discretionary bonus for services in fiscal 2025. These options were issued under the 2025 Equity Incentive Plan and relate to the company’s common stock.
How many stock options did Hayward Marshall receive from Jupiter Neurosciences (JUNS)?
Hayward Marshall received 259,231 stock options. Each option is exercisable for one share of Jupiter Neurosciences common stock, giving him rights over 259,231 underlying shares, all reflected as his total option holdings after the reported grant.
What is the exercise price of the stock options granted to Hayward Marshall at JUNS?
The stock options granted to Hayward Marshall have an exercise price of $0.2783 per share. This is the price he must pay to acquire each share of common stock if he chooses to exercise the options before they expire.
When do Hayward Marshall’s Jupiter Neurosciences (JUNS) options vest?
The options vest over three years starting September 2, 2026, in equal quarterly installments. Vesting is conditioned on Hayward Marshall’s continued employment through each vesting date, meaning he earns the rights to exercise portions of the grant over time.
When do the stock options granted to Hayward Marshall by JUNS expire?
The stock options granted to Hayward Marshall expire on June 2, 2036. He may exercise vested options any time before this expiration date, subject to the terms of the 2025 Equity Incentive Plan and his continued eligibility.
What plan governs the new stock option grant to Hayward Marshall at Jupiter Neurosciences?
The new stock option grant is issued under Jupiter Neurosciences’ 2025 Equity Incentive Plan. This plan governs the terms of equity-based awards, including vesting schedule, exercise price, expiration date, and conditions tied to continued employment or service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
